| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/08/2009 | WO2009004214A2 Method for preparing lipid nanoparticles |
| 01/08/2009 | WO2009004039A2 Hard gelatin capsule formulation comprising a pumpkin product |
| 01/08/2009 | WO2009003991A1 Composition containing at least one nutritive, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 01/08/2009 | WO2009003965A1 Injectable veterinary composition with anti-prolactin activity |
| 01/08/2009 | WO2009003960A1 Stable double emulsions |
| 01/08/2009 | WO2009003724A1 Tolterodine bead |
| 01/08/2009 | WO2009003466A1 Reservoir system comprising a closed membrane |
| 01/08/2009 | WO2009003463A2 Use of deuterium oxide for treating virus-based skin diseases |
| 01/08/2009 | WO2009003356A1 A pharmaceutical composition for decreasing the area of myocardial infarct and application thereof |
| 01/08/2009 | WO2009003307A1 Phthiobuzonum derivatives and preparation, pharmaceutical composition and use thereof |
| 01/08/2009 | WO2008138612A3 Substrate promoting angiogenesis |
| 01/08/2009 | WO2008122425A3 Oral compositions containing tacrolimus in amorphous form |
| 01/08/2009 | WO2008121721A3 Targeted delivery and expression of procoagulant hemostatic activity |
| 01/08/2009 | WO2008120128A3 System and method for pill communication and control |
| 01/08/2009 | WO2008118133A3 Silk microspheres for encapsulation and controlled release |
| 01/08/2009 | WO2008117117A3 Compositions and method for hair loss prevention |
| 01/08/2009 | WO2008106646A3 Methods and formulations for topical gene therapy |
| 01/08/2009 | WO2008101175A3 Protein formulations containing sorbitol |
| 01/08/2009 | WO2008017331A3 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 01/08/2009 | WO2008005287A8 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/08/2009 | WO2007029198A3 Sanitary napkins with hydrophobic lotions |
| 01/08/2009 | WO2006078979A3 Vectors and methods for genetic immunization |
| 01/08/2009 | US20090012503 Body-Insertable Apparatus |
| 01/08/2009 | US20090012502 Oxygen Supply for Cell Transplant and Vascularization |
| 01/08/2009 | US20090012159 High purity bases of 3,3-diphenylpropylamino monoesters |
| 01/08/2009 | US20090012150 Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance |
| 01/08/2009 | US20090012064 Compositions controlling pH range of release and/or release rate |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090011980 Method of Treating Parkinson's Disease in Humans by Direct Infusion of Glial Cell-Line Derived Neurotrophic Factor Into the Zona Incerta |
| 01/08/2009 | US20090011040 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases |
| 01/08/2009 | US20090011039 Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof |
| 01/08/2009 | US20090011038 Drug-Delivery Systems |
| 01/08/2009 | US20090011037 Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011035 Personal care composition |
| 01/08/2009 | US20090011034 Sustained release micropellets and process for producing the same |
| 01/08/2009 | US20090011033 Process for the manufacture of cellulose sulfate with improved characteristics |
| 01/08/2009 | US20090011032 Methods for improved cryo-chemotherapy tissue ablation |
| 01/08/2009 | US20090011031 Delivery of oral drugs |
| 01/08/2009 | US20090011030 Breakthrough pain management |
| 01/08/2009 | US20090011029 Colorless and transparent antibiotic material including silver, and a method for the preparation of it |
| 01/08/2009 | US20090011028 Self-precipitating pharmaceutical formulations for the moified release of an active principle |
| 01/08/2009 | US20090011027 Modifying Drug Release in Suspensions of Ionic Resin Systems |
| 01/08/2009 | US20090011026 Transcorneal system for delivery of a pharmaceutical agent |
| 01/08/2009 | US20090011025 Biotin-Amino Acid Conjugate Useful as a Hydrogelator and Hydrogel Prepared Therefrom |
| 01/08/2009 | US20090011024 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers |
| 01/08/2009 | US20090011023 Chemotherapeutic compositions |
| 01/08/2009 | US20090011022 Use of deuterium oxide for treatment of virus-based diseases of the skin |
| 01/08/2009 | US20090011021 Engineered Extracellular Matrices |
| 01/08/2009 | US20090011020 Gastroresistant Pharmaceutical Formulations Containing Rifaximin |
| 01/08/2009 | US20090011019 Pharmaceutical compositions for gastrointestinal drug delivery |
| 01/08/2009 | US20090011018 Sustained release formulation for tacrolimus |
| 01/08/2009 | US20090011017 Polymers based on water-soluble monoolefinic comprising colloidal silica and their use as matrix polymers for solid dosage forms |
| 01/08/2009 | US20090011016 Crush-Resistant Oxycodone Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion |
| 01/08/2009 | US20090011015 Method for promoting sleep |
| 01/08/2009 | US20090011014 Tablet Formulation for Sustained Drug-Release |
| 01/08/2009 | US20090011013 Tacrolimus Combination Products |
| 01/08/2009 | US20090011012 Fatty acid compositions and methods of use |
| 01/08/2009 | US20090011011 Stable dosage formulations of imidazolylalkyl-pyridines |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090011009 Microspheres comprising nanocapsules containing a lipophilic drug |
| 01/08/2009 | US20090011008 Nanoparticles for protein drug delivery |
| 01/08/2009 | US20090011007 Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water |
| 01/08/2009 | US20090011006 Once daily formulations of tetracyclines |
| 01/08/2009 | US20090011005 Pharmaceuticals compositions containing nanomaterials useful for treating restenotic lesions |
| 01/08/2009 | US20090011004 Improved carriers for delivery of nucleic acid agents to cells and tissues |
| 01/08/2009 | US20090011003 Composition for Suppressing Expression of Target Gene |
| 01/08/2009 | US20090011002 Nano - and Mesosized Particles Comprising an Inorganic Core, Process and Applications Thereof |
| 01/08/2009 | US20090011001 Manufacturing process for liposomal preparations |
| 01/08/2009 | US20090011000 Inhibitors of Infection |
| 01/08/2009 | US20090010999 Complex Particles and Coated Complex Particles |
| 01/08/2009 | US20090010998 Drug-delivery patch comprising a dissolvable layer and uses thereof |
| 01/08/2009 | US20090010995 Patch and patch preparation |
| 01/08/2009 | US20090010993 Composition comprising polyphenol |
| 01/08/2009 | US20090010992 Drug formulations for oral transmucosal delivery to pediatric patients |
| 01/08/2009 | US20090010991 Nasal Passage Stent |
| 01/08/2009 | US20090010989 Coating For Implants and Implants With Improved Osteointegration, and Manufacturing Method |
| 01/08/2009 | US20090010988 Composition of bone formation with phsrn-rgd containing oligopeptide |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010985 Article with Lubricated Surface and Method |
| 01/08/2009 | US20090010980 Materials coatings and methods for self-cleaning and self-decontamination of metal surface |
| 01/08/2009 | US20090010978 Green tea jewelry |
| 01/08/2009 | US20090010975 Non-transparent composition for film |
| 01/08/2009 | US20090010973 Silicas |
| 01/08/2009 | US20090010968 Spot-on formulation useful for cosmetology and dermatology |
| 01/08/2009 | US20090010914 Use of Oligouronates for Treating Mucus Hyperviscosity |
| 01/08/2009 | US20090010869 Compositions for Topical Enzymatic Debridement |
| 01/08/2009 | US20090010854 Pulmonary insulin crystals |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090008820 Injection Molded Water-Soluble Container |
| 01/08/2009 | US20090007906 Methods and Formulations for the Efficient Delivery of Drugs by Nebulizer |
| 01/08/2009 | DE102007028462A1 Oxygen capsules, useful for oxygen inhalation purpose, comprises a coating agent of shellac and talcum |
| 01/08/2009 | DE102007026853A1 Nicotindepot, insbesondere für eine rauchfreie Zigarette, sowie Verfahren zu dessen Herstellung Nicotine depot, especially for a smokeless cigarette, and processes for the production thereof |
| 01/08/2009 | CA2704147A1 Chemical modification of maleated fatty acids |
| 01/08/2009 | CA2692364A1 Reservoir system comprising a closed membrane |
| 01/08/2009 | CA2692231A1 Liquid protein formulations comprising gdf-5 for use at elevated temperatures |
| 01/08/2009 | CA2692146A1 Dual portion lozenge dosage form |
| 01/08/2009 | CA2691787A1 Soft gel systems in modulating stem cell development |
| 01/08/2009 | CA2690479A1 Method for preparing lipid nanoparticles |